Literature DB >> 17168848

Surfactant protein A--from genes to human lung diseases.

S Heinrich1, D Hartl, M Griese.   

Abstract

Surfactant associated protein-A (SP-A) is the most abundant pulmonary surfactant protein and belongs to the family of innate host defense proteins termed collectins. Besides pulmonary host defense, SP-A is also involved in the formation of pulmonary surfactant, as it is essential for the structure of tubular myelin. The human SP-A gene locus includes two functional genes, SFTPA1 and SFTPA2 which are expressed independently, and a pseudo gene. The largest amount of SP-A1 proteins assemble to larger molecular complexes, whereas SP-A2 forms mainly dimers and trimers. SP-A polymorphisms play a role in respiratory distress syndrome, allergic bronchopulmonary aspergillosis and idiopathic pulmonary fibrosis. The levels of SP-A are decreased in the lungs of patients with cystic fibrosis, respiratory distress syndrome and further chronic lung diseases. Future areas for clinical research include disease specific SP-A expression pattern and their functional consequences, the differential roles of SP-A1 and SP-A2 in human lung diseases, and therapeutical approaches to correct altered SP-A levels.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17168848     DOI: 10.2174/092986706778773112

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  11 in total

1.  Surfactant protein-A (SP-A) selectively inhibits prostaglandin F2alpha (PGF2alpha) production in term decidua: implications for the onset of labor.

Authors:  Victoria V Snegovskikh; Vineet Bhandari; Jo Rae Wright; Serkalem Tadesse; Thomas Morgan; Colin Macneill; Nastaran Foyouzi; Joong Shin Park; Yuguang Wang; Errol R Norwitz
Journal:  J Clin Endocrinol Metab       Date:  2011-01-26       Impact factor: 5.958

2.  On the evolution of development.

Authors:  John S Torday
Journal:  Trends Dev Biol       Date:  2014

3.  A central theory of biology.

Authors:  John S Torday
Journal:  Med Hypotheses       Date:  2015-04-04       Impact factor: 1.538

Review 4.  An overview of pulmonary surfactant in the neonate: genetics, metabolism, and the role of surfactant in health and disease.

Authors:  Paul O Nkadi; T Allen Merritt; De-Ann M Pillers
Journal:  Mol Genet Metab       Date:  2009-02-04       Impact factor: 4.797

5.  Palmitoylation of cytoskeleton associated protein 4 by DHHC2 regulates antiproliferative factor-mediated signaling.

Authors:  Sonia L Planey; Susan K Keay; Chen-Ou Zhang; David A Zacharias
Journal:  Mol Biol Cell       Date:  2009-01-14       Impact factor: 4.138

Review 6.  Lung surfactant alterations in pulmonary thromboembolism.

Authors:  A Calkovska; D Mokra; V Calkovsky
Journal:  Eur J Med Res       Date:  2009-12-07       Impact factor: 2.175

7.  Surfactant protein a in cystic fibrosis: supratrimeric structure and pulmonary outcome.

Authors:  Matthias Griese; Stephanie Heinrich; Felix Ratjen; Michael Kabesch; Karl Paul; Manfred Ballmann; Ernst Rietschel; Matthias Kappler
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

8.  Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types.

Authors:  Li Peng; Xiu Wu Bian; Di Kang Li; Chuan Xu; Guang Ming Wang; Qing You Xia; Qing Xiong
Journal:  Sci Rep       Date:  2015-08-21       Impact factor: 4.379

9.  Emergence of respiratory Streptococcus agalactiae isolates in cystic fibrosis patients.

Authors:  Vera Eickel; Barbara Kahl; Beatrice Reinisch; Angelika Dübbers; Peter Küster; Claudia Brandt; Barbara Spellerberg
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

10.  Novel molecular tumor cell markers in regional lymph nodes and blood samples from patients undergoing surgery for non-small cell lung cancer.

Authors:  Oddmund Nordgård; Gurpartap Singh; Steinar Solberg; Lars Jørgensen; Ann Rita Halvorsen; Rune Smaaland; Odd Terje Brustugun; Åslaug Helland
Journal:  PLoS One       Date:  2013-05-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.